Tilray, Inc. (TLRY)
| Market Cap | 7.22B |
| Revenue (ttm) | 210.48M |
| Net Income (ttm) | -271.07M |
| Shares Out | 446.16M |
| EPS (ttm) | -1.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $15.13 |
| Previous Close | $16.18 |
| Change ($) | -1.06 |
| Change (%) | -6.52% |
| Day's Open | 16.40 |
| Day's Range | 14.87 - 16.43 |
| Day's Volume | 22,575,094 |
| 52-Week Range | 4.41 - 67.00 |
Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -90.00% and -22.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
As investors were so righteously reminded on Friday, many of the day-to-day Wall Street prognostications and strategy calls are almost always “best guesses” or data-based “assumptions.
Disappointing earnings from Aphria played a large role in Tilray's move.
Analysts are high on the cannabis company's growth prospects.
The lagging index got a nice boost to finish the week on Friday.
Tilray soars on double upgrade from Jefferies
Jefferies calls the match with Aphria a 'perfect match.' With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Steve Grasso, James McDonald and Nadine Terman.
Tilray Inc. (NASDAQ:TLRY) shares were trading higher Friday after a Jefferies analyst double upgraded the stock. The stock was double upgraded from Underperform to Buy and the price target was raised fr...
Analyst explains why he upgraded Tilray to a buy
Tilray shares are soaring after Jefferies gave the stock a double upgrade. Owen Bennett, Jefferies, joins 'Power Lunch' to discuss why he upgraded Tilray to a buy and breaks down the company's fundament...
More than 550 U.S.-listed companies are reporting quarterly results on the first three days of next week, May 10 through 12.
The merger between Tilray Inc (NASDAQ: TLRY) and Aphria was a “perfect match” and the entity could generate pro-forma sales growth of 33% between fiscal 2021 and 2024, according to Jefferies. The Tilray...
Cannabis stocks are on the move Friday morning with many of the major players seeing shares increasing on two pieces of news. The post Cannabis Stocks: 2 Big Reasons TLRY, CGC, GRWG, SNDL Stocks Are Get...
Wall Street is mostly stoked about the cannabis stock's potential.
Last December, two Canada-based pot growers, Tilray Inc. (NASDAQ: TLRY) and Aphria, announced a merger that closed Monday, with Tilray the surviving company at a market cap of around $8.2 billion.
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) announced that as of today, May 5, 2021, its shares of class 2 common stock (the “Tilray Shares”) have commenced trading on the T...
A mega-merger marks a historic day for the legalized cannabis industry -- and a chance to load up on TLRY stock as a pot-market giant emerges. The post Tilray Becomes Pot's Biggest As Investors Say Good...
Are Canadian Marijuana Stocks Positioned For Future Gains? The post How Do You Invest In Marijuana Stocks? 2 Canadian Pot Stocks To Watch In May appeared first on Marijuana Stocks | Cannabis Investments...
The combined company is taking the Tilray name.
New Tilray CEO Irwin Simon discusses building a global cannabis brand
Tilray shareholders voted to approve the merger with Aphria. New Tilray CEO Irwin Simon joins 'Closing Bell' to discuss the outlook of the cannabis brand.
Tilray, Inc. (NASDAQ: TLRY) and Aphria, Inc. (NASDAQ:APHA) have merged after months of negotiations, creating a company with a combined market cap of $3.3 billion. The two Canadian cannabis giants had b...
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports first-quarter 2021 results.
The shares of Tilray Inc (NASDAQ:TLRY) are down 2.9% at $17.82 at last check, after the cannabis company announced the completion of its merger with sector rival Aphria (APHA).
NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new era...
Canadian Cannabis Stocks For Your Portfolio In May The post Are These The Top Canadian Marijuana Stocks To Buy Next Week? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a B...
Tilray-Aphria deal approved in cannabis mega-merger
The Tilray and Aphria deal has been approved. Yahoo Finance Canada Senior Writer Jeff Lagerquist joins Yahoo Finance's Aikiko Fujita and Zack Guzman to discuss.
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
The Chartmaster grades Tim Seymour's Stock Draft picks
Cornerstone Macro's Carter Worth gives a technical breakdown of Tim Seymour's Stock Draft picks. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Dan Nathan.
Expect the Tilray-Aphria merger to be approved on April 30. But TLRY stock will likely fall once the merger goes through since it may take time for synergies to work.
Today, cannabis stocks are taking off as enthusiasm appears to be building in this hyper-growth segment of the market once again. The post Cannabis Stocks: Why HEXO, TLRY, APHA, CGC Stocks Gained Today ...
How to approach and invest in the cannabis industry the Foolish way.
Shares of cannabis companies such as Tilray, Inc. (NASDAQ:TLRY) and Canopy Growth Corporation (NASDAQ:CGC) are trading higher after BofA Securities reinstated a Buy rating on the stocks. BofA Securities...
Valuation multiples for cannabis stocks are likely to expand over the next year as the U.S. government reaches milestones on the path to federal cannabis legalization, according to BofA Securities. The ...
It would be fair to say that cannabis stocks received three positive indicators over the past six months.
Top Picks In 2021 For Canadian Cannabis Stocks The post Top Canadian Marijuana Stocks For Your Portfolio In 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding In...
Tilray, Inc. (TLRY) closed at $17.72 in the latest trading session, marking a -0.73% move from the prior day.
TLRY Stock is highly overvalued with a growth runway that cannot justify its post-merger valuation with Aphria The post Tilray Stock Has Valuation Problems That a Merger Just Won't Solve appeared first ...
NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the company has been inclu...
These cannabis producers already have a presence south of the border.
Aphria's dismal Q2 results show that the cannabis sector hasn't overcome its structural challenges, while U.S. legalization is unlikely. Investors should sell APHA stock.
The Tilray-Aphria merger looks intriguing on its face. But soft earnings and questions about the combined company make APHA stock an avoid.
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
Are These Top Cannabis Stocks To Invest In Right Now? The post Looking For Marijuana Stocks To Buy On Robinhood? 2 For Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments ...
On the hunt for bargains? Here's how these three stocks can add muscle to your portfolio.
The sector has been red-hot this past year, and even mediocre stocks have done well.
About TLRY
Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia,... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jul 19, 2018 |
| CEO Brendan Kennedy | Employees 1,200 |
| Stock Exchange NASDAQ | Ticker Symbol TLRY |
Financial Performance
In 2020, Tilray's revenue was $210.48 million, an increase of 26.05% compared to the previous year's $166.98 million. Losses were -$271.07 million, -15.60% less than in 2019.
Analyst Forecasts
According to 15 analysts, the average rating for Tilray stock is "Hold." The 12-month stock price forecast is 18.98, which is an increase of 25.49% from the latest price.